Archive for June, 2020

$GGBXF 420 with CNW – Why NJ Medical Cannabis is Slated to Get a Lot Cheaper

On July 1, New Jersey is slated to reduce the sales tax on medical marijuana from 6.625% to 4%. This move is the first in a series of measures that will see state sales taxes removed entirely within a space of three years. On July 1 next year, the tax will reduce to 2% and the following year (July 1, 2022) will see the reduction to a 0% state sales tax.

However, the sales tax reforms which roll out tomorrow don’t mean that buyers of medical marijuana will not pay any taxes on their purchases. Municipalities within New Jersey are still allowed to impose a 2% sales tax within their jurisdictions, but so far, no town has invoked this provision to levy the tax.

The plan to phase out sales taxes on medical marijuana were part of the Jake Honig Compassionate Use Act enacted into law last year. The bill was named after Jake Honig, a 7-year old kid from Howell who had an inoperable tumor in the brain. Only medical marijuana gave him any relief until he passed in 2018.

Activists raised an uproar about the sales taxes imposed by the state on medical marijuana. This outcry was prompted by the fact that prescription medications are exempted from state sales tax. The activists therefore wanted medical marijuana to be regarded in the same way since it is a prescription medicine in New Jersey.

While the bill was being debated in the state legislature, several lawmakers called the sales tax “criminal” since working class and poor families would suffer an added burden while acquiring the medicine they need.

Currently, more than 77,000 people are registered on the state’s medical marijuana program. However, supply chain problems and the resulting prohibitive prices (medical marijuana can cost approximately $500 an ounce) have plagued the progress of the sector.

As the tax cuts kick in, an ounce of medical marijuana will drop to about $469.15. This will bring some relief to patients, and as the supply issues are sorted, prices could drop even further.

At the moment, only nine clinics are open to sell medical pot to patients across the state. Other locations that were pre-approved haven’t opened their doors to customers due to ongoing legal battles.

In November, New Jersey voters are slated to vote on a ballot measure that could see recreational marijuana legalized. If the bill passes, dispensaries will be allowed to sell recreational marijuana to adults who are 21 or older.

The reduction of the state sales tax on medical marijuana is likely to be welcomed by the entire industry, including Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) since it makes products more affordable for patients.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Tuesday, June 30th, 2020 Uncategorized Comments Off on $GGBXF 420 with CNW – Why NJ Medical Cannabis is Slated to Get a Lot Cheaper

$POAI Secures $2.2M Through Warrant Exercise

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday announced the closing of its previously announced transaction. According to the update, Predictive Oncology secured approximately $2.2 million in gross cash proceeds from the transaction, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock, each at an exercise price of $1.575. The shares of common stock issued upon exercise of the existing warrants are registered for resale pursuant to a registration statement on Form S-1 (File No. 333-239207). The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

To view the full press release, visit http://nnw.fm/0SJ0o

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 30th, 2020 Uncategorized Comments Off on $POAI Secures $2.2M Through Warrant Exercise

$PBIO and Leica Microsystems Collaborate to Offer Innovative Combined Workflow Expected to Accelerate Cancer R&D

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced its entry into a worldwide co-marketing agreement with German-based Leica Microsystems CMS GmbH, a Danaher company. Per the update, the historic alliance is expected to offer transformative new empowerment to cancer research worldwide through integrating the latest enabling technologies in capturing, isolating and preparing biopsy samples for superior analysis of relevant biomarkers of disease state and treatment response. “The generation of reliable and reproducible data from biopsy samples is difficult, as it requires the integration of multiple and varied laboratory processes, particularly tissue extraction, sample preparation, and analysis,” Roxana McCloskey, PBI’s Global Director of Sales & Marketing, stated in the news release. “The innovative LMD-PCT workflow enables the reproducible and rapid extraction of proteins from precious clinical samples by combining the precision of the Leica LMD system with PBI’s versatile PCT sample preparation platform. The ability to co-market the workflow offers the opportunity for the combined sales and marketing forces of Leica and PBI to extend the integrated LMD-PCT systems into additional research centers globally that are focused on clinical proteomics, cancer research, biomarker discovery, and precision medicine.”

To view the full press release, visit http://nnw.fm/38KYp

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 30th, 2020 Uncategorized Comments Off on $PBIO and Leica Microsystems Collaborate to Offer Innovative Combined Workflow Expected to Accelerate Cancer R&D

$ICLK Recognized for Big Data in Advertising at SBR’s Technology Excellence Awards 2020

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has been named winner of the Big Data Award in the advertising category at Singapore Business Review’s (“SBR”) second Technology Excellence Awards 2020. Held annually by SBR, a leading business magazine serving Singapore’s dynamic business community, the Technology Excellence Awards recognize outstanding companies worldwide that have made exceptional contributions in pursuit of technological innovation. “We are thrilled to receive this award from Singapore Business Review which further recognizes iClick’s leadership in the international digital marketing industry,” Jian “T.J.” Tang, iClick’s CEO and co-founder, stated in the news release. “Drawing on our cutting-edge technologies and robust data resources, iClick will persist in our mission to relentlessly develop and upgrade our intelligent marketing solutions to help global clients build presence and successfully fuel growth in China with the best and the most efficient data-driven, one-stop marketing solutions, as we continue our evolution into a fully integrated marketing and enterprise cloud platform.”

To view the full press release, visit http://nnw.fm/jQFM1

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, its proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe.

For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://nnw.fm/ICLK

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 30th, 2020 Uncategorized Comments Off on $ICLK Recognized for Big Data in Advertising at SBR’s Technology Excellence Awards 2020

$SRAX Big Data Analytics Delivers During the Pandemic

NetworkNewsWire Editorial Coverage: Despite lockdowns, creative data analytics and digital marketing deliver incredible results.

As the nation’s economy slammed shut due to the pandemic, certain sectors seemed to defy the severity of the situation. The digital world seemed to defy gravity, generating ever more interest and expediting uptake out of necessity. A recent press release from SRAX Inc. (NASDAQ: SRAX) (SRAX Profile) is a prime example of such gravity-defying action and may be a harbinger of what’s to come. Leveraging in-depth investor intelligence and big data analytics, SRAX uses proprietary technology to creatively unlock and utilize data in new powerful ways to create a new nexus of opportunity between public companies, financiers, investors and traders. SRAX just released news on Sequire, the company’s innovative technology platform for comprehensive investor intelligence, corporate communications and shareholder retention and acquisition. From launch just over a year ago, Sequire has grown its client base to over 75 publicly traded companies, amassing an aggregate 500,000+ active investors and traders  as sales have exploded in Q2 2020. What makes Sequire so attractive with such rapid uptake is that for the first-time public companies can monitor investors and activate media campaigns to engage existing investors and attract new ones. SRAX’s technology delivers public companies unparalleled insights into investors’ behaviors and trends and newfound ability to use those insights to engage investors across various marketing channels. Leveraging data and resources from Broadridge Financial Solutions Inc. (NYSE: BR), a leading provider of communications and data and analytics solutions, Sequire has attracted public companies across a wide spectrum of industries and delivered notable results from its platform for such diverse companies as Genius Brands International Inc. (NASDAQ: GNUS)a children’s entertainment media company; Can B Corp. (OTCQB: CANB) a health & wellness company; and Wrap Technologies Inc. (NASDAQ: WRTC), an innovator of modern policing solutions.

Accelerated Uptake

The adoption of technology and the digitization of business has been underway for decades. Changes were evolving long before coronavirus, but the pandemic hypersonically accelerated the evolution. Companies that were obliquely considering digital solutions a few years ago are now embracing them as part of the new normal, establishing business relationships for a long-term digital future. Whether through Zoom meetings, virtual conferences or digital marketing, companies in nearly every industry are pivoting to adapt to the crisis. The virus has hastened the digital transition so fast that customers across every sector are flocking to technology solutions as digital platforms reap the benefits. This transition to technology is no passing fad and is expected to permanently alter the way business is conducted and social interactions occur. Nowhere is this transition more needed or welcomed than in the complex interactions between public companies and their current and future shareholders. Roadshows and investor conferences are suddenly lumbering dinosaurs while virtual meetings lack sizzle and have limited appeal. Innovative new strategies and creative big data solutions are at the heart of establishing a new paradigm in investor intelligence, and corporate communications and will set the standard for decades to come.

Data Centric Solutions

It’s a common understanding that data is collected and analyzed, but data alone is useless until it’s been parsed and massaged in some manner to create actionable intelligence. The optimization and monetization of data is a multibillion-dollar global business – data and business analytics solutions reached $166 billion in 2018, and it is projected to explode to $260 billion in just two years.  SRAX (NASDAQ: SRAX) (SRAX Profile), a rapidly growing, innovative consumer data management technology company, is carving an enviable niche in this explosive market. SRAX uniquely unlocks the value of data, integrating all aspects of the digital marketing and advertising experience, including verified consumer participation, all into one platform. Through its Sequire technology platform, SRAX is monetizing datasets and growing recurring revenue streams by delivering a digital competitive advantage for clients. Recent news at Sequire offers crystal clear insight into the company’s parabolic growth potential. Using proprietary processes, unique data management technology and digital marketing acumen, Sequire has experienced incredible growth from its launch just over a year ago, expanding its client base to over 75 publicly traded companies in the U.S. and Canada. Sequire posted record sales of over $2.5M in Q2 2020, servicing an aggregate of 500K+ investors and traders that issuers have on the platform. These ballooning numbers indicate an accelerated uptake of Sequire’s unique investor relations services, long a stumbling block for publicly traded companies.

Some of this accelerated uptake may be attributed to the pandemic, but platform efficacy is paramount – clients come and stay because it works, delivering new digital competitive advantages. Through Sequire, public companies can now monitor and track retail and institutional investors then activate media campaigns to engage existing investors and simultaneously attract new ones. Sequire can identify traits of current investors and is then able to market directly to subgroups to attract liked minded shareholders. Public companies never had it so good, especially ones providing niche products services. This has long been the bane of public companies – how to effectively interact and communicate with current shareholders and—even more importantly—how to appeal to and attract new shareholders. Never before has such an effective solution been provided to the investor relations dilemma faced by publicly traded companies.

This news comes on the heels of last week’s eyepopping revelation that SRAX had entered into a definitive securities purchase agreement led by existing institutional investors for the purchase and sale of an aggregate of $13 million senior secured convertible debentures to fund the rapid expansion of Sequire. Pegged at an above-market fixed conversion price of $2.69, the deal appears to be another strong vote of confidence from institutional investors in the viability and future of SRAX’s technology as well as an endorsement of the market value of data analytics and digital marketing.

“On Thursday, we announced a capital raise of $13M, which we will use in part to fund the rapid expansion of Sequire,” said SRAX CEO and founder Christopher Miglino. “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5M and an additional $3M in the pipeline, with a very high probability of closing in Q3.”

To translate, Sequire has a high probability of reaching a 200% quarter-over-quarter increase in sales in the midst of a crippling global pandemic – hard to imagine any stronger validation of efficacy and accelerated uptake of SRAX’s technology and services.

In new powerful ways, public companies using Sequire now track their investors’ behaviors and trends and use those insights to engage current and potential investors across multiple marketing channels. By uniquely marrying data management and digital marketing, Sequire unlocks investor behaviors and trends, even providing public companies the ability to identify who is buying and selling stock. Then, using these newfound detailed insights, these companies can pique and capture the interest of existing investors as well as attract new investors.

Sequire gives public companies the power to:

  • Monitor shareholders’ behaviors from a company’s data sets over time
  • Analyze activity from market makers and see the biggest gains and losses
  • Uncover trends over time from buyer and sellers
  • Track ROI from investor relations programs
  • Assign shareholder credit to investor relations firms
  • Turn real-time conference visitor data into targeted cross-channel ads
  • Reach potential investors based on current stock buyer behaviors and trends
  • Target current stock buyers to promote a higher return from existing relationships

Putting power into finger tips, Sequire also offers an multi-feature innovative mobile APP and more information can be found at MySequire.com.

SRAX has an extensive background and acumen in data management and digital advertising as well as deep understanding how to strategically interact with different brands. The rapid acceptance and adoption of SRAX’s product offering in the midst of a pandemic, strong institutional investor support, and the accelerated embracement of digital solutions definitely makes SRAX one to watch.

Just a Few of a Growing Number

Broadridge Financial Solutions, Inc. (NYSE: BR) is a $4 billion global fintech leader, provides investor communications and technology-driven solutions for broker-dealers, banks, mutual funds and corporate issuers globally. Broadridge’s investor communications, securities processing and managed services solutions help clients reduce their capital investments in operations infrastructure, allowing them to increase their focus on core business activities.

Genius Brands International, Inc. (NASDAQ: GNUS) is a leading global media company that develops, produces, markets and licenses branded children’s entertainment properties and consumer products for media and retail distribution. The company distributes its content worldwide in all formats, as well as a broad range of consumer products based on its characters. The Genius Brands Network currently reaches 80 million U.S. households with continued expansion planned both in the U.S. and internationally.

Wrap Technologies, Inc. (NASDAQ: WRTC) is an innovator of modern policing solutions. The company’s BolaWrap product is a patented, hand-held remote restraint device that discharges an 8-foot bola style Kevlar(R) tether to entangle an individual at a range of 10-25 feet. The small but powerful BolaWrap 100 assists law enforcement to control encounters safely and effectively.

Can B Corp. (OTCQB: CANB) is a health & wellness company providing some of the highest grade and purity cannabidiol (CBD) products available under multiple recognized brands. “Sequire is an essential tool for any CEO to understand what is going on with their stock and for their ability to communicate with their investors and find new ones,” said Can B Corp. CEO Marco Alfonsi. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. The company owns and operates an R&D and production facility in Lacey, WA, and Green Grow Farms, a licensed hemp grower and cultivator in New York.

For more information on SRAX Inc., please visit SRAX Inc. (NASDAQ: SRAX).

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Tuesday, June 30th, 2020 Uncategorized Comments Off on $SRAX Big Data Analytics Delivers During the Pandemic

$GGBXF Announces Expiry of Forbearance Agreement with Green Ops

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Friday announced the expiration of the forbearance period (“Forbearance Period”) pursuant to the terms of the forbearance agreement (the “Forbearance Agreement”) with Green Ops Group LLC (“Green Ops”) previously announced on May 20, 2020.  Per the update, the expiration of the Forbearance Period entitles Green Ops to exercise any and all of its rights under the loan documents and applicable law, and GGB is precluded from contesting any such enforcement action under a separate Voluntary Surrender of Collateral in Satisfaction of Debt and Release Agreement among the parties.

To view the full press release, visit http://cnw.fm/uNA9H

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source and 8 Fold. GGB is continuing its cannabis operations throughout the U.S., via dispensaries in Nevada and Massachusetts. Learn more about the vision at GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Monday, June 29th, 2020 Uncategorized Comments Off on $GGBXF Announces Expiry of Forbearance Agreement with Green Ops

$POAI Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants

MINNEAPOLIS, June 29, 2020 — Predictive Oncology Inc. (the “Company,” “Predictive Oncology,” “we,” “our” or “us”) (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously announced transaction resulting in gross cash proceeds to the Company of approximately $2.2 million, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock at an exercise price of $1.575 per share. The shares of common stock issued upon exercise of the existing warrants are registered for resale pursuant to a registration statement on Form S-1 (File No. 333-239207).

In consideration for the immediate exercise of the existing warrants for cash, the exercising holders received new unregistered warrants to purchase up to an aggregate of 1,396,826 shares of common stock at an exercise price of $1.80 per share with an exercise period of five and one-half years from the date of issuance.

The Company expects to use the net proceeds from this offering for working capital and general corporate purposes.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), and, along with the shares of common stock issuable upon the exercise thereof, have not been registered under the Securities Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. The Company has agreed to file one or more registration statements with the Securities and Exchange Commission covering the resale of the shares of common stock issuable upon exercise of the warrants.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

Forward-Looking Statements

Certain of the matters discussed in this press release, including the intended use of the proceeds from the transaction described herein, are forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include: we may not be able to continue operating without additional financing; current negative operating cash flows; the terms of any further financing, which may be highly dilutive and may include onerous terms; risks related to the 2019 merger with Helomics including; 1) significant goodwill could result in further impairment; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources; risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns; risks related to the transaction with Quantitative Medicine including: 1) completion of the transaction; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources; risk that we will be unable to protect our intellectual property or claims that we are infringing on others’ intellectual property; the impact of competition; acquisition and maintenance of any necessary regulatory clearances applicable to applications of our technology; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; risk that we never become profitable if our product is not accepted by potential customers; possible impact of government regulation and scrutiny; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse results of any legal proceedings; the volatility of our operating results and financial condition; and management of growth. In addition, our business and operations have been and will likely continue to be materially and adversely affected by the COVD-19 pandemic, including impact on a significant supplier; a reduction in on-site staff at several of our facilities, resulting in delayed production and less efficiency; impact on sales efforts; impact on accounts receivable and terms demanded by suppliers; and possible impact on financing transactions; resulting in a possible continued material adverse effect on our business, financial condition and results of operations. These and other risks and uncertainties may be detailed from time to time in the Company’s reports filed with the SEC, which are available for review at www.sec.gov.

Investor Relations Contact:

Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com

Monday, June 29th, 2020 Uncategorized Comments Off on $POAI Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants

$MEDS Gains Inclusion on Russell Index for the Coming Year

  • Trxade Group Inc. facilitates the procurement and delivery of prescription drugs to a growing network of independent pharmacies, positioning them to compete with much larger national chains
  • Trxade’s healthtech platform facilitates remote-access patient-provider consultations through its developing Bonum Health Hub smart technology-optimized services, which proves particularly useful during the present pandemic
  • The company is slated to be included in the Russell Microcap Index when Russell’s annual index reconstitution is completed by month’s end
  • Inclusion in the Russell index, as well as the recent undertaking of research report coverage by investment services firm Taglich Brothers, and the company’s uplisting to the NASDAQ market in February are helping Trxade to build its investor profile

Prescription drug procurement and healthcare services innovator Trxade Group (NASDAQ: MEDS), is celebrating another benchmark in its growth strategy following the announcement it will be included in Russell’s Microcap Index when the global index powerhouse completes the annual reconstitution of its market index measurements of the largest U.S. stocks by category following the market close on June 26, going into effect as markets open Monday, June 29 (http://nnw.fm/f2AEC).

FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98 percent of the investable market globally, and Russell’s indexes have been used for over 30 years by asset owners and managers to judge their investments’ performance and make investment product decisions.

Trxade Group has been nurturing a healthtech brand that values affordability, transparency and equal access to medical community patients by expanding its network of independent pharmacies and empowering them to better deliver medications through the effective use of technology.

Investment analysis media outlet Alphastreet recently noted that the rise in online pharmaceutical purchasing over the past decade and the heightened attention to remote-access medical care brought on by the present coronavirus pandemic are positioning Trxade’s independent pharmacies to compete with bigger healthcare retailers such as CVS Health or Walgreens Boots Alliance (http://nnw.fm/Ui4Yr).

After its acquisition of Internet drug outlet company Community Specialty Pharmacy, LLC, two years ago (http://nnw.fm/4cVb3), Trxade was able to advance its prescription drug distribution platform and add a “Health Hub” virtual examination platform via technology for private, secure patient-physician consultations last year (http://nnw.fm/33g9O), which helped drive the company’s stock uplisting on The NASDAQ Capital Market in February (http://nnw.fm/WI2en).

“In the retrospect, Trxade ticks three requirements that value investors look for in stocks: a comfortable balance sheet, the ability to make profits and plenty of headroom for growth,” Alphastreet stated.

Trxade’s addition to the Russell Microcap Index helps the integrated drug and healthcare platform raise its profile among the investment community, furthering its potential to generate long-term shareholder value while limiting marketing expenses.

“This marks an exciting capital markets milestone in the growth and trajectory of our company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community,” Trxade Chairman and CEO Suren Ajjarapu stated in the news release about the Russell listing.

About $9 trillion in assets are benchmarked against Russell’s US indexes, according to the news release.

Ajjarapu appeared in a webinar presentation June 24 to provide an overview of the company’s business model and growth initiatives. A replay of the webinar can be viewed at http://nnw.fm/Boz14 or by dialing 1-844-512-2921 within the United States, or 1-412-317-6671 from international locations, and entering replay pin number 13705066 through July 8.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, June 29th, 2020 Uncategorized Comments Off on $MEDS Gains Inclusion on Russell Index for the Coming Year

$SRAX Announces Significant Growth of Its Investor Intelligence and Communications Platform

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced that its investor intelligence and communications platform, Sequire, has surpassed 500,000 active investors and traders while sales have exceeded $2.5 million in Q2 2020. According to the update, Sequire has shown rapid growth since its early 2019 launch, expanding its client base to over 75 publicly traded companies in the U.S. and Canada. “On Thursday, we announced a capital raise of $13M, which we will use in part to fund the rapid expansion of Sequire,” Christopher Miglino, founder and CEO of SRAX, stated in the news release. “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5M and an additional $3M in the pipeline, with a very high probability of closing in Q3.”

To view the full press release, visit http://nnw.fm/8aTrG

About SRAX

SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, June 29th, 2020 Uncategorized Comments Off on $SRAX Announces Significant Growth of Its Investor Intelligence and Communications Platform

$GNPX Joins Russell 3000(R) Index

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it was added to the Russell 3000(R) Index after the market closed on Friday, June 26, 2020 as part of the 2020 Russell U.S. Indexes reconstitution. “Genprex is excited to be a member of the Russell 3000 Index, and we look forward to sharing our story and unique approaches for the treatment of lung cancer and diabetes with a wider group of investors,” Rodney Varner, chairman and CEO of Genprex, stated in the news release. “We believe the Company’s future is bright as we work to secure better outcomes for patients suffering from these serious medical conditions.”

To view the full press release, visit http://nnw.fm/e9fTg

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, June 29th, 2020 Uncategorized Comments Off on $GNPX Joins Russell 3000(R) Index

$JMDA Announces Strategic Expansion of Leadership Team

Jerrick Media Holdings (OTCQB: JMDA), a technology company and the parent company of Vocal, today announced the appointment of three new executives to its leadership team. According to the update, the Company named Chelsea Pullano as chief financial officer (“CFO”), effective immediately. In addition, upon Jerrick’s planned NASDAQ uplisting this summer, Danielle Banner will be formally named chief revenue officer (“CRO”) and Robby Tal as chief strategy officer (“CSO”). “As we head into our shareholder meeting, we have assembled the right team to manage our transition from the OTCQB to the NASDAQ Capital Markets,” Jerrick’s president and Head of Product Justin Maury stated in the news release. “With the combined strength of our employees as a whole, and with Officers of the high caliber that Chelsea, Danielle, and Robby represent, our team represents the ideal collective to execute on both our product expansion and our corporate vision.”

To view the full press release, visit http://nnw.fm/KzM2v

About Jerrick

Jerrick Media Holdings, Inc. is the parent company and creator of the Vocal platform. The Company creates technology-based solutions to solve problems for the creative community. Through Vocal, Jerrick identifies and leverages opportunities within the digital platform and content monetization space. Since launching in 2016, Vocal has become home to over 600,000 content creators and brands of all shapes and sizes, attracting audiences across its network of wholly owned and operated communities. For more information, visit the Company’s website at https://Jerrick.media.

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, June 29th, 2020 Uncategorized Comments Off on $JMDA Announces Strategic Expansion of Leadership Team

$WRTC Secures New Follow-On Order for Major Police Force

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its receipt of a new follow-on order for 21,600 additional BolaWrap cartridges for the Indonesia National Police force. The Company previously reported the fulfillment of an initial order of devices and cartridges placed by its distributor in Indonesia at the end of 2019. Following successful BolaWrap demonstrations across the country, the Company’s distributor recently secured a contract with the Indonesian National Police force. “We are very pleased to see both new international orders and follow-on orders such as this one for a major police force,” Tom Smith, president at Wrap Technologies, stated in the news release. “We believe this order reflects the Indonesian National Police force’s acceptance of the BolaWrap as a viable solution to an age-old challenge in policing – safely detaining noncompliant subjects without injury.”

To view the full press release, visit http://nnw.fm/h1EYl

About Wrap Technologies (NASDAQ: WRTC)

Wrap Technologies is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.WrapTechnologies.com. Examples of recent media coverage are available as links under the “Media” tab of the website.

NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, June 29th, 2020 Uncategorized Comments Off on $WRTC Secures New Follow-On Order for Major Police Force

$POAI Subsidiary Leverages Unique Patient-Derived Platform to Assist Oncologists

Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is providing clinical decision support tools to support oncologists in personalizing cancer treatment. A recent article discussing the company further reads, “Through its unique patient derived (PDx) platform, which tests the drug response and biomarker profile of the patient’s own tumor, and its vast database of historical tumor profiles, Helomics provides clinical decision support tools today to assist oncologists in individualizing cancer treatment. . . . Precision medicine is based on the idea of customizing health care, making medical decisions and selecting treatments, practices and prescriptions that are tailored to each individual patient rather than a recommended general treatment approach. A recent Acumen Research and Reporting article noted that the global precision medicine market is expected to reach total market value of approximately $84 billion by 2026 with anticipated CAGR growth of around 10% in terms of revenue between 2019 and 2026 (http://nnw.fm/tQAG2).”

To view the full article, visit http://nnw.fm/ixH1H

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions, by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, June 26th, 2020 Uncategorized Comments Off on $POAI Subsidiary Leverages Unique Patient-Derived Platform to Assist Oncologists

$GGBXF Announces Expiration of Forbearance Agreement Related to Spring Oaks Greenhouses, Inc.

COLUMBUS, Ohio, June 26, 2020 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or the “Company“) announced today the expiry of the forbearance period (“Forbearance Period”) pursuant to the terms of the forbearance agreement (the “Forbearance Agreement”) with Green Ops Group LLC (“Green Ops”) previously announced on May 20, 2020.  The expiration of the Forbearance Period entitles Green Ops to exercise any and all of its rights under the loan documents and applicable law, and GGB is precluded from contesting any such enforcement action under a separate Voluntary Surrender of Collateral in Satisfaction of Debt and Release Agreement among the parties. The Company has also received a letter from legal counsel to Green Ops notifying the Company of the acceleration of all secured obligations of the Company under the Forbearance Agreement and that all guaranteed obligations of the Company owing to Green Ops are immediately due and payable in full. The Company has been notified that Green Ops intends to enforce its righs under such loan documents and applicable law through the seizure of collateral granted by the Company and the Grantors (as defined in the Forbearance Agreement).

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is continuing its cannabis operations throughout the U.S., via dispensaries in Nevada and Massachusetts. Learn more about the vision at GreenGrowthBrands.com.

For investor relations inquiries, please contact:

Randy Whitaker
Chief Executive Officer
Green Growth Brands Inc.
rwhitaker@greengrowthbrands.com
1-800-282-8462

Friday, June 26th, 2020 Uncategorized Comments Off on $GGBXF Announces Expiration of Forbearance Agreement Related to Spring Oaks Greenhouses, Inc.

$UUUU Finalizes Agreements with Rare Earth Element Industry Experts to Advance Commercial, Technical Strategies

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, recently finalized consulting agreements with two rare earth element (“REE”) industry experts, Constantine Karayannopoulos and Brock O’Kelley. The experts will consult with the company on the development and implementation of commercial and technical REE strategies for the new U.S. REE program (http://nnw.fm/z82zF). An article discussing the company reads, “The company previously announced that it is entering the U.S. rare earths space by potentially leveraging its existing White Mesa Mill in Utah to produce high-value rare earth concentrates. If successful, the mill would play a critical role in restoring a U.S. rare earths supply chain. . . . ‘Energy Fuels is extremely excited to bring Constantine Karayannopoulos and Brock O’Kelley on board to advance our entry into the rare earth space in the U.S.,’ UUUU president and CEO Mark S. Chalmers stated in a news release. ‘Over the past year or so, Energy Fuels has been actively evaluating this rare earth opportunity. We are quickly coming to the conclusion that the White Mesa Mill may be an ideal U.S. facility to process rare earth element ore streams and produce rare earth concentrates. Mr. Karayannopoulos and Mr. O’Kelley will assist Energy Fuels in the commercial and technical aspects of this endeavor.’”

To view the full article, visit http://nnw.fm/I816b

About Energy Fuels

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the United States today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S., including several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU; the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, June 26th, 2020 Uncategorized Comments Off on $UUUU Finalizes Agreements with Rare Earth Element Industry Experts to Advance Commercial, Technical Strategies

$BHAT Enters Strategic Partnership to Establish Short Video Live Streaming DTC Model

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its partnership with Xiamen Xing Meng Wei Lai Culture Media Co. LTD (“Xing Meng Wei Lai”) , a leading Chinese multi-channel network (“MCN”) and internet content development agency, to build Direct-to-Consumer (“DTC”) social content marketing channels via short videos and live streaming. “Establishing a short video live streaming DTC sales model is a milestone for Blue Hat because it not only serves to increase our brand awareness, but also to broaden our market reach,” Xiaodong Chen, CEO of Blue Hat, stated in the news release. “We believe that combining the power of short video live streaming with the reach of standard e-commerce platforms will be an important driver of Blue Hat’s online sales looking forward. With our comprehensive online and offline sales network, we believe we are building future revenue growth for our products.”

To view the full press release, visit http://nnw.fm/Q8iFm

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile game features. The Company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the Company’s investor relations website at www.IR.BlueHatGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, June 25th, 2020 Uncategorized Comments Off on $BHAT Enters Strategic Partnership to Establish Short Video Live Streaming DTC Model

$GNPX Announces Another Step in Advancement of Lead Drug Candidate for NSCLC

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that the United States Adopted Names (“USAN”) Council has approved the non-proprietary name quaratusugene ozeplasmid for GPX-001, formerly called Oncoprex(TM) immunogene therapy, the Company’s lead drug candidate for non-small cell lung cancer (“NSCLC”). “The USAN’s adoption of our non-proprietary name is another step toward advancing our lead drug candidate, GPX-001 for non-small cell lung cancer, toward commercialization,” Rodney Varner, chairman and CEO of Genprex, stated in the news release. “We look forward to the adoption and rollout of a brand name for this drug as we continue to move along the development pathway. In the meantime, we’ve focused our branding efforts on our proprietary, non-viral nanoparticle delivery system with our recognized Oncoprex(TM) name. We believe this delivery system is a significant differentiator for GPX-001, as well as an important platform delivery system that could be used for additional drug candidates.”

To view the full press release, visit http://nnw.fm/sY7OR

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, June 25th, 2020 Uncategorized Comments Off on $GNPX Announces Another Step in Advancement of Lead Drug Candidate for NSCLC

$GGBXF 420 with CNW – US April Marijuana Sales Remain Strong Despite Coronavirus Pandemic

The coronavirus pandemic has dealt a massive blow to the economy, and experts say it will take years to recover to pre-pandemic levels. State governments ordered the closure of all non-essential businesses, coupled with social distancing and self-isolation to curb the spread of the virus, but these measures wreaked havoc on the economy. Several industries have been almost been brought to a standstill as the country waits for the virus to pass, resulting in millions of job losses. However, one industry that seems to be weathering the storm is cannabis.

Many states with legal cannabis programs declared the industry essential, allowing cannabis dispensaries to continue operations amid COVID-19 related shutdowns. In some states, home deliveries and curbside deliveries were also allowed to reduce contact between staff and customers. In the weeks leading up to the shutdowns, cannabis shops reported increased sales as customers stocked up for the coming weeks they would spend in self-isolation. And, as broader retail sales fell by double digits in April, cannabis sales stayed strong. According to data from BDS Analytics, some states reported higher numbers in April than in March when demand spiked.

In April, Oregon stood out among states that have legalized marijuana. According to data from BDS Analyitcs, there was a 40% sales growth in April versus 31% in March and 19% in January. States that have regulated medical marijuana programs but do not allow recreational marijuana had even stronger gains. Sales in Maryland doubled and in Arizona they jumped nearly 50%. Nevada’s cannabis industry is more dependent on tourism than other states, and it saw a 30% drop in sales.

The 20th of April, affectionately called 4/20, is the unofficial cannabis holiday, and it has seen increased sales in previous years. This year, however, the biggest pot celebration day fell smack dab in the middle of the coronavirus crisis, and sales weren’t as great as they could have been. In Colorado and California, sales were 62% and 55% above the year-to-date average respectively compared to 148% and 135% increases in 2019. According to data from Headset Inc., overall sales in Colorado, Nevada, Washington and California fell 22% from 2019.

According to wholesale cannabis marketplace LeafLink Inc., the average share of concentrate products (commonly found in vapes) increased 30% during the week after Father’s Day last year compared to the week before. However, the products that seem to generate more demand on Father’s Day were dad-friendly products like cannabis cigars, mocktails and resins. Surprisingly, lip balms saw a 79% jump while breath strips and sublinguals’ sales increased 55%.

This is likely to be seen by sector players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) as further proof of the economic benefits of having a regulated marijuana market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Thursday, June 25th, 2020 Uncategorized Comments Off on $GGBXF 420 with CNW – US April Marijuana Sales Remain Strong Despite Coronavirus Pandemic

$SRAX Raises $13M for Rapid Expansion of Investor Intelligence, Data Analytics and Communications Platform

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced its entry into definitive securities purchase agreements led by existing institutional investors for the purchase and sale of an aggregate of $13 million senior secured convertible debentures at an above market fixed conversion price of $2.69. According to the update, the Company intends to use the proceeds to fund the rapid expansion of its investor intelligence, data analytics and communications platform, Sequire.

To view the full press release, visit http://nnw.fm/OY5fD

About SRAX

SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, June 25th, 2020 Uncategorized Comments Off on $SRAX Raises $13M for Rapid Expansion of Investor Intelligence, Data Analytics and Communications Platform

$MEDS Brings Taglich Brothers Onboard to Build Brand Reporting, Welcomes New Bonum Health President

  • Trxade Group Inc. is a growing B2B pharmaceutical network that provides solutions to small healthcare businesses, care providers and medical patients through growing optimization of remote-access health services
  • Amid the sweep of the global COVID-19 pandemic, Trxade Group has continued to build its vision of enabling the health industry to operate transparently and effectively even as the importance of changing remote-access medicine models grows
  • Trxade Group recently began receiving research report coverage from investment services firm Taglich Brothers, Inc. as part of ongoing brand-building efforts
  • The company also recently announced that experienced healthcare market advisory professional Ashton Maaraba has been named president of Trxade Group’s Bonum Health telemedicine practice and will guide new patient acquisition

Growing prescription drug delivery and healthcare services innovator Trxade Group (NASDAQ: MEDS) continues to nurture a brand built on the vision of officers intent on providing affordability, transparency and equal access to medical community patients through effective technology. The company recently announced that investment services firm Taglich Brothers, Inc. has begun providing coverage to Trxade through its research division (http://nnw.fm/sSOt8).

Trxade’s efforts to expand its network of independent pharmacies and empower them to better deliver medications regardless of competition from larger retail chains have resulted in an upswell of brand-building and marketing outreach during the past several months.

After Trxade’s acquisition of Internet drug outlet company Community Specialty Pharmacy, LLC, (http://nnw.fm/wrNq4) the company began building a remote-access “secure virtual examination room” for patient-physician consultation through a “Health Hub” initiative that partners with the company’s drug delivery services (http://nnw.fm/3mHKC).

Trxade then began listing its common stock on The NASDAQ Capital Market in February as part of its efforts to increase its visibility, stability and ability to attract new investment (http://nnw.fm/uTO4r),  even as the novel coronavirus pandemic was beginning to make itself known throughout the world. Trxade helped respond to concerns about limited testing for the new virus by rolling out an FDA-approved rapid point-of-care skin prick test to help medical professionals triage patients with potential COVID symptoms (http://nnw.fm/0Oknn).

Trxade’s developments are helping to position the company to deliver value to the health care market in coming days as nations recover from their initial shock at seeing populations decimated by the pandemic and begin working with confidence on providing health solutions and solutions that address economic and lifestyle needs.

“We believe our platform will become even more important for our customers in the years to come. We have a clear vision of our strategy and the opportunities ahead and look forward to another successful year of growth,” Board Chairman and CEO Suren Ajjarapu stated earlier this year in a report on the company’s 2019 achievements (http://nnw.fm/jA8tM).

The Taglich Brothers coverage involves an agreement for Taglich to create and disseminate research reports on Trxade and its market. Trxade has paid for the initial two months, which will begin reporting in September, and will begin paying a monthly service amount for ongoing reporting after that initial period has expired.

Trxade also recently announced the appointment of former AshHealth healthcare market advisory firm President Ashton Maaraba as president of Trxade Group’s Bonum Health telemedicine practice.

Maaraba has over 20 years of experience in developing and directing strategic national sales, marketing and operating initiatives in ever-changing, dynamic environments, according to the company, and will work to help build long-term shareholder value by welcoming a growing number of patients under the Bonum Health Hub platform.

“Ashton is an intuitive leader with acute business acumen and expertise in channel development and market development,” Trxade Group CEO Suren Ajjarapu stated in describing the company’s forward strategy (http://nnw.fm/8hFn9). “I am confident in his ability to drive widespread adoption of Bonum Health amongst both employers seeking to provide unique healthcare perks to their workers as well as to individuals seeking a low-cost, convenient way to speak with a doctor.”

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, June 24th, 2020 Uncategorized Comments Off on $MEDS Brings Taglich Brothers Onboard to Build Brand Reporting, Welcomes New Bonum Health President